|
|
|
|
| LEADER |
03433nma a2201021 u 4500 |
| 001 |
EB002196949 |
| 003 |
EBX01000000000000001334414 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
240202 ||| eng |
| 020 |
|
|
|a 9783036597034
|
| 020 |
|
|
|a books978-3-0365-9702-7
|
| 020 |
|
|
|a 9783036597027
|
| 100 |
1 |
|
|a Kourti, Maria
|
| 245 |
0 |
0 |
|a Prognostic Factors for Pediatric Tumors
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (196 p.)
|
| 653 |
|
|
|a overall survival
|
| 653 |
|
|
|a risk factors
|
| 653 |
|
|
|a genetics
|
| 653 |
|
|
|a undernutrition
|
| 653 |
|
|
|a non-coding RNAs
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a copy-number alterations (CNAs)
|
| 653 |
|
|
|a diagnosis
|
| 653 |
|
|
|a Oncology / bicssc
|
| 653 |
|
|
|a radiation
|
| 653 |
|
|
|a fertility-sparing surgery
|
| 653 |
|
|
|a genital tract
|
| 653 |
|
|
|a neoadjuvant chemotherapy
|
| 653 |
|
|
|a review
|
| 653 |
|
|
|a chemotherapeutics agents
|
| 653 |
|
|
|a pediatrics
|
| 653 |
|
|
|a child
|
| 653 |
|
|
|a childhood cancer
|
| 653 |
|
|
|a proto-oncogene B-raf gene (BRAF)
|
| 653 |
|
|
|a minimal residual disease (MRD)
|
| 653 |
|
|
|a tumor
|
| 653 |
|
|
|a micro-RNAs
|
| 653 |
|
|
|a embryonal rhabdomyosarcoma
|
| 653 |
|
|
|a nutritional status
|
| 653 |
|
|
|a children
|
| 653 |
|
|
|a craniopharyngioma
|
| 653 |
|
|
|a relapse
|
| 653 |
|
|
|a therapy
|
| 653 |
|
|
|a guidelines
|
| 653 |
|
|
|a medulloblastoma
|
| 653 |
|
|
|a oncology
|
| 653 |
|
|
|a recurrence
|
| 653 |
|
|
|a papillary thyroid cancer
|
| 653 |
|
|
|a acute lymphoblastic leukemia (ALL)
|
| 653 |
|
|
|a adolescents
|
| 653 |
|
|
|a CDKN2A/2B deletions
|
| 653 |
|
|
|a biomarkers
|
| 653 |
|
|
|a omics technology
|
| 653 |
|
|
|a multiple-ligation probe amplification (MLPA)
|
| 653 |
|
|
|a prognosis
|
| 653 |
|
|
|a histologic
|
| 653 |
|
|
|a obesity
|
| 653 |
|
|
|a molecular subgroup
|
| 653 |
|
|
|a proteomics
|
| 653 |
|
|
|a treatment
|
| 653 |
|
|
|a ovarian cancer
|
| 653 |
|
|
|a cardiotoxicity
|
| 653 |
|
|
|a stratification
|
| 653 |
|
|
|a fluorescent in situ hybridization (FISH)
|
| 653 |
|
|
|a event-free survival
|
| 653 |
|
|
|a chemotherapy
|
| 653 |
|
|
|a acute lymphoblastic leukemia
|
| 653 |
|
|
|a local debulking
|
| 653 |
|
|
|a risk stratification
|
| 653 |
|
|
|a cardiac function tests
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a treatment-related toxicity
|
| 653 |
|
|
|a youth
|
| 653 |
|
|
|a sarcoma botryoides
|
| 700 |
1 |
|
|a Hatzipantelis, Emmanouel
|
| 700 |
1 |
|
|a Kourti, Maria
|
| 700 |
1 |
|
|a Hatzipantelis, Emmanouel
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-9702-7
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/132453
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/8493
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 600
|
| 520 |
|
|
|a In this Special Issue, recent advancements in the field of pediatric tumors are discussed, and novel prognostic markers are critically appraised. Greater understanding of the heterogeneity of pediatric cancers will ultimately lead to new therapeutic strategies with the potential to provide new prospects for precision medicine in pediatric oncology.
|